Key information

Gentian Diagnostics AS serves the global market with sensitive diagnostic tests. Current and pipeline products contribute to improved diagnostics and cost reductions in treatment of kidneys, inflammation, cardiovascular diseases, cancer and viral infections.

On 14th December, 2016, Gentian Diagnostics AS was admitted to the Oslo Stock Exchange list ‘Merkur Market’ under GENT-ME.

Find more information about the Gentian Share on Oslo Børs.
Learn more about Gentian Diagnostics AS here.

Financial Calendar 2020

14TH FEB - QUARTERLY REPORT- Q4

24TH APR - ANNUAL REPORT

24TH APR - QUARTERLY REPORT - Q1

14TH MAY - ANNUAL GENERAL MEETING

21ST AUG - HALF-YEARLY REPORT

29TH OCT - QUARTERLY REPORT - Q3

 

Financial Calendar 2019

9TH MAY – ANNUAL REPORT

9TH MAY – QUARTERLY REPORT Q1

28TH MAY – ANNUAL GENERAL MEETING

15TH AUG – HALF–YEARLY REPORT

7TH NOV – QUARTERLY REPORT – Q3

Extraordinary General Meeting Gentian Diagnostics AS 21/11/2019

The Extraordinary General Meeting for Gentian Diagnostics AS was hold on the 21st of November 2019.

For more information, please see the documents below

28th of May 2019: Annual General Meeting

Annual General Meeting for Gentian Diagnostics AS was hold on the 28th of May 2019. For more information, please see the notice and documents below:

Presentations

Historicals

Look at our historical archive to find financial reports and data from 2018, 2017 and 2016.